Oncocyte Corporation
15 Cushing
Irvine, California 92618
| July 26, 2021 |
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Chris Edwards
| Re: | Oncocyte Corporation |
| Registration Statement on Form S-3 | |
| File No. 333-257905 |
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Oncocyte Corporation (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Thursday, July 29, 2021, or as soon thereafter as possible.
Please notify Kandace Watson of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (858) 720-8930 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
| ONCOCYTE CORPORATION | ||
| By: | /s/ Mitchell Levine | |
| Name: | Mitchell Levine | |
| Title: | Chief Financial Officer | |
| - 1 - |
